Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Navamedic ASA

Market Cap 411M 43.15M 37.23M 34.26M 32.17M 59.96M 4.09B 61.01M 405M 158M 2B 162M 158M 6.9B P/E Ratio 2026 *
286x
P/E Ratio 2027 * 25.6x
Enterprise Value 517M 54.27M 46.82M 43.09M 40.46M 75.42M 5.14B 76.74M 509M 199M 2.51B 204M 199M 8.68B EV / Sales 2026 *
0.87x
EV / Sales 2027 * 0.71x
Free-Float
71.72%
Yield 2026 *
-
Yield 2027 * -
1 day+2.39%
1 week+2.08%
Current month-2.83%
1 month-8.78%
3 months-17.55%
6 months-31.94%
Current year-27.94%
1 week 16.5
Extreme 16.5
18
1 month 16.5
Extreme 16.5
18.95
Current year 16.5
Extreme 16.5
24.5
1 year 16.5
Extreme 16.5
27.9
3 years 16.5
Extreme 16.5
43.9
5 years 16.5
Extreme 16.5
43.9
10 years 8
Extreme 8
43.9
Manager TitleAgeSince
Chief Executive Officer 60 2018-12-31
Director of Finance/CFO - 2025-12-31
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 2022-05-31
Director/Board Member - 2023-05-31
Director/Board Member 60 2024-05-31
Date Insider Type Main position Quantity % Market Cap.
24-12-18Buy

Chief Operating Officer

10,267 0.0581%
24-09-08Fiscal year

Chief Executive Officer

80,000 0.4589%
24-09-08Fiscal year

Executive/Senior Manager

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+2.39%+2.08%-20.23%-55.45% 42.33M
-0.32%-0.18%+37.83%+152.24% 1,010B
-2.16%+1.24%+50.01%+45.87% 580B
-2.70%-2.48%+15.97%+62.66% 402B
+0.77%0.00%+21.28%+19.14% 330B
-1.52%+1.90%+23.73%+34.08% 281B
-1.95%-4.75%+20.15%+14.68% 280B
-0.57%+0.62%-44.67%-47.65% 197B
-1.31%+0.27%+18.74%+57.70% 192B
-0.38%-3.76%+13.02%+59.46% 156B
Average +0.26%+0.73%+13.58%+34.27% 342.88B
Weighted average by Cap. +0.03%+1.04%+26.19%+68.99%

Financials

2026 *2027 *
Net sales 595M 62.43M 53.86M 49.56M 46.54M 86.75M 5.91B 88.27M 586M 229M 2.89B 234M 229M 9.99B 661M 69.35M 59.83M 55.06M 51.71M 96.37M 6.57B 98.06M 651M 254M 3.21B 260M 255M 11.1B
Net income 1M 105K 90.52K 83.3K 78.22K 146K 9.94M 148K 984K 385K 4.86M 394K 385K 16.79M 16M 1.68M 1.45M 1.33M 1.25M 2.33M 159M 2.37M 15.75M 6.15M 77.7M 6.3M 6.17M 269M
Net Debt 106M 11.12M 9.59M 8.83M 8.29M 15.45M 1.05B 15.73M 104M 40.77M 515M 41.73M 40.84M 1.78B 57M 5.98M 5.16M 4.75M 4.46M 8.31M 566M 8.46M 56.11M 21.92M 277M 22.44M 21.96M 957M
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
26-06-15 17.15 kr +2.39% 3,563
26-06-12 16.75 kr -0.89% 27,050
26-06-11 16.90 kr -1.74% 8,580
26-06-10 17.20 kr 0.00% 5,410
26-06-09 17.20 kr +1.47% 19,656
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
17.15NOK
Average target price
26.00NOK
Spread / Average Target
+51.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!